C-MYC-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent

被引:86
|
作者
Trudel, M [1 ]
Lanoix, J [1 ]
Barisoni, L [1 ]
Blouin, MJ [1 ]
Desforges, M [1 ]
LItalien, C [1 ]
DAgati, V [1 ]
机构
[1] COLUMBIA UNIV COLL PHYS & SURG, DEPT PATHOL, NEW YORK, NY 10032 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1997年 / 186卷 / 11期
关键词
D O I
10.1084/jem.186.11.1873
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The SBM mouse is a unique transgenic model of polycystic kidney disease (PKD) induced by the dysregulated expression of c-myc in renal tissue. In situ hybridization analysis demonstrated intense signal for the c-myc transgene overlying tubular cystic epithelium in SBM mice. Renal proliferation index in SBM kidneys was 10-fold increased over nontransgenic controls correlating with the presence of epithelial hyperplasia. The specificity of c-myc for the proliferative potential of epithelial cells was demonstrated by substitution of c-myc with the proto-oncogene c-fos or the transforming growth factor (TGF)-alpha within the same construct. No renal abnormalities were detected in 13 transgenic lines established, indicating that the PKD phenotype is dependent on functions specific to c-myc. We also investigated another well characterized function of c-myc, the regulation of apoptosis through pathways involving p53 and members of the bcl-2 family, which induce and inhibit apoptosis, respectively. The SBM kidney tissues, which overexpress c-myc, displayed a markedly elevated (10-100-fold) apoptotic index. However, no significant difference in bcl-2, bax, or p53 expression was observed in SBM kidney compared with controls. Direct proof that the heightened renal cellular apoptosis in PKD is not occurring through p53 was obtained by successive matings between SBM and p53(-/-) mice. All SBM offspring, irrespective of their p53 genotype, developed PKD with increased renal epithelial apoptotic index. In addition, overexpression of both bcl-2 and c-myc in double transgenic mice (SBB+/SBM+) also produced a similar PKD phenotype with a high apoptotic rate, showing that c-myc can bypass bcl-2 in vivo. Thus, the in vivo c-myc apoptotic pathway in SBM mice occurs through a p53- and bcl-2-independent mechanism. We conclude that the pathogenesis of PKD is c-myc specific and involves a critical imbalance between the opposing processes of cell proliferation and apoptosis.
引用
收藏
页码:1873 / 1884
页数:12
相关论文
共 50 条
  • [31] C-MYC AND BCL-2 MODULATE P53 FUNCTION BY ALTERING P53 SUBCELLULAR TRAFFICKING DURING THE CELL-CYCLE
    RYAN, JJ
    PROCHOWNIK, E
    GOTTLIEB, CA
    APEL, IJ
    MERINO, R
    NUNEZ, G
    CLARKE, MF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) : 5878 - 5882
  • [32] The master regulators Myc and p53 cellular signaling and functions in polycystic kidney disease
    Kurbegovic, Almira
    Trudel, Marie
    CELLULAR SIGNALLING, 2020, 71
  • [33] Bromocriptine induced apoptosis in pituitary adenoma cells: relationship to p53 and bcl-2 expression
    Yin, DL
    Tamaki, N
    Kokunai, T
    Yasuo, K
    Yonezawa, K
    JOURNAL OF CLINICAL NEUROSCIENCE, 1999, 6 (04) : 326 - 331
  • [34] Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers
    Chan, WY
    Cheung, KK
    Schorge, JO
    Huang, LW
    Welch, WR
    Bell, DA
    Berkowitz, RS
    Mok, SC
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02): : 409 - 417
  • [35] bcl-2 and p53 in endometrial adenocarcinoma
    Taskin, M
    Lallas, TA
    Barber, HRK
    Shevchuk, MM
    MODERN PATHOLOGY, 1997, 10 (07) : 728 - 734
  • [36] Effects of xenoestrogens on T lymphocytes: Modulation of bcl-2, p53, and apoptosis
    Ndebele, K
    Tchounwou, PB
    McMurray, RW
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2003, 4 (02) : 45 - 61
  • [37] bcl-2, p53 immunophenotypes and apoptosis in squamous cell carcinoma of the oesophagus
    Sur, M
    Cooper, K
    HISTOPATHOLOGY, 1998, 33 (01) : 87 - 88
  • [38] Expression of p53 and bcl-2 in cholangiocarcinomas
    Arora, DS
    Wyatt, JI
    JOURNAL OF PATHOLOGY, 1997, 182 : A35 - A35
  • [39] Analysis of bcl-2, p53 expression and apoptosis during colorectal carcinogenesis
    Orii, S
    Takano, Y
    Tazawa, H
    Hashimoto, Y
    Takahashi, H
    Nakamura, S
    Iwasaki, M
    GASTROENTEROLOGY, 1999, 116 (04) : A480 - A481
  • [40] bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer
    Popescu, RA
    Lohri, A
    de Kant, E
    Thiede, C
    Reuter, J
    Herrmann, R
    Rochlitz, CF
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (08) : 1268 - 1273